The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Arrowhead Pharmaceuticals, Inc(NASDAQ:ARWR) 
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated wi...
Website: http://arrowheadpharma.com
Founded: 1989
Full Time Employees: 232
Sector: Healthcare
Industry: Biotechnology
Arrowhead Pharmaceuticals Days Payable Outstanding ttm (DPO)
Arrowhead Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Arrowhead Pharmaceuticals Op Cashflow Per Share ttm
Arrowhead Pharmaceuticals Free Cashflow Per Share ttm
Arrowhead Pharmaceuticals Cash Per Share ttm
Arrowhead Pharmaceuticals P/S ratio ttm
Arrowhead Pharmaceuticals (GAAP) P/E ratio ttm
Arrowhead Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.